Fig. 1From: Efficacy and safety of low-dose rituximab as induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement: a Chinese case seriesChanges of lymphocytes and IgG in 1 year after RTX or CYC administration. RTX vs baseline: *P < 0.05, **P < 0.01. CYC vs baseline: #P < 0.05, ##P < 0.01. CYC vs RTX: &P < 0.05, &&P < 0.01Back to article page